Lupus anticoagulants
Sidor, C.F.; Martin, S.E.; Abel, R.; Blatt, P.M.
Delaware Medical Journal 58(4): 239-245
1986
ISSN/ISBN: 0011-7781 PMID: 3086143 Document Number: 271302
Document emailed within 1 workday
Related Documents
Exner, T.; Triplett, D.A.; Taberner, D.; Machin, S.J. 1991: Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants Thrombosis and Haemostasis 65(3): 320-322Brandt, J.T.; Triplett, D.A.; Alving, B.; Scharrer, I. 1995: Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH Thrombosis and Haemostasis 74(4): 1185-1190
Triplett, D.A. 2003: Lupus anticoagulants: diagnosis and management Current Hematology Reports 2(4): 271-272
Durán-Suárez, J.R. 1983: Circulating anticoagulants in systemic lupus erythematosus Medicina Clinica 81(5): 203-206
Matuszewska, E.; Grygalewicz, J.; Wygledowska, G.; Mazurkiewicz, H. 2003: The evaluation of natural anticoagulants in systemic lupus erythematosus in children Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 14(80): 125-129
Lieberman, D.; Sharon, R.; Bassan, L. 1984: Circulating anticoagulants of the lupus type in asymptomatic primary biliary cirrhosis Harefuah 107(11): 334-336
Aldawood, A.S.; Crowther, M.; Jaeschke, R.; Dabbagh, O.; Alkhairy, K.; Baharoon, S.; Ahmed, N. 2005: The incidence and impact of lupus anticoagulants among patients in the intensive care unit Saudi Medical Journal 26(12): 1994-1995
Harger, J.H.; Laifer, S.A.; Bontempo, F.A.; Senich, L.A.; Church, C. 1995: Low-dose aspirin and prednisone treatment of pregnancy loss caused by lupus anticoagulants Journal of Perinatology: Official Journal of the California Perinatal Association 15(6): 463-469
Guermazi, S.; Gorgi, Y.; Ayed, K.; Dellagi, K. 1997: Interference of factor VIIi excess on the detection of lupus anticoagulants by the activated partial thromboplastin time Pathologie-Biologie 45(1): 28-33
Della Valle, P.; Crippa, L.; Safa, O.; Tomassini, L.; Pattarini, E.; Vigano-D'Angelo, S.; Grazia Sabbadini, M.; D'Angelo, A. 1996: Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants Annales de Medecine Interne 147(Suppl): 10-14
Brandt, J.T.; Triplett, D.A.; Rock, W.A.; Bovill, E.G.; Arkin, C.F. 1991: Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologists survey program Archives of Pathology and Laboratory Medicine 115(2): 109-114
Chantarangkul, V.; Tripodi, A.; Clerici, M.; Bressi, C.; Mannucci, P.Mannuccio. 2002: Laboratory diagnosis of lupus anticoagulants--effect of residual platelets in plasma, assessed by Staclot LA and silica clotting time Thrombosis and Haemostasis 87(5): 854-858
Eschwège, V.; Seddiki, S.; Robert, A. 1996: The tissue thromboplastin inhibition test in the detection of lupus anticoagulants: importance of a correction factor eliminating the influence of fibrinogen level Thrombosis and Haemostasis 76(1): 65-68
Tripodi, A.; Chantarangkul, V.; Clerici, M.; Mannucci, P.M. 2002: Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA Thrombosis and Haemostasis 88(4): 583-586
Goudemand, J.; Caron, C.; De Prost, D.; Derlon, A.; Borg, J.Y.; Sampol, J.; Sié, P. 1997: Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants. the Working Group on Hemostasis of the Société Française de Biologie Clinique and for the Groupe d'Etudes sur I'Hémostase et la Thrombose Thrombosis and Haemostasis 77(2): 336-342
Gianetti, J.; Gensini, G.; De Caterina, R. 1998: A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants Thrombosis and Haemostasis 80(6): 887-893
Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526
Raleigh-Rosendo, R.; Diez-Ewald, M.; Vizcaíno, G.; Fereira, H.; Arteaga-Vizcaíno, M.; Arreaza, M. 1990: Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities Investigacion Clinica 31(1): 45-55
Asherson, R.A.; Lanham, J.G.; Hull, R.G.; Boey, M.L.; Gharavi, A.E.; Hughes, G.R. 1984: Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant" Clinical and Experimental Rheumatology 2(1): 75-79
Leong, K.P.; Tee, N.W.; Yap, W.M.; Chee, T.S.; Koh, E.T. 2000: Nocardiosis in patients with systemic lupus erythematosus. the Singapore Lupus Study Group Journal of Rheumatology 27(5): 1306-1312